Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
380.23
+7.57 (2.03%)
Feb 20, 2026, 4:00 PM EST - Market closed
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medsurg and Neurotechnology | 15.65B | 14.97B | 14.39B | 13.73B | 13.22B | 12.77B | 12.40B | 12.15B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Medsurg and Neurotechnology Growth | 18.34% | 17.23% | 16.01% | 13.08% | 11.71% | 11.40% | 10.84% | 11.65% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Orthopedics and Spine | 9.47B | 9.41B | 9.43B | 9.48B | 9.37B | 9.21B | 8.99B | 8.82B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Orthopedics and Spine Growth | 1.02% | 2.25% | 4.93% | 7.55% | 8.21% | 9.28% | 8.72% | 9.21% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Medsurg | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.98B | 6.82B | 6.40B | 6.40B | 6.38B | 6.36B | 6.65B | 6.57B | ||||||||
| Medsurg Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.32% | 7.30% | -3.80% | -2.65% | -1.15% | 0.55% | 7.95% | 8.75% | ||||||||
| Orthopedics | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.17B | 5.96B | 5.22B | 4.96B | 4.90B | 4.85B | 5.22B | 5.25B | ||||||||
| Orthopedics Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.86% | 22.91% | -0.06% | -5.58% | -5.06% | -4.44% | 3.96% | 5.23% | ||||||||
| Neurotechnology | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.52B | 3.47B | 3.10B | 2.99B | 2.94B | 2.87B | 3.08B | 3.06B | ||||||||
| Neurotechnology Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.99% | 21.00% | 0.52% | -2.16% | 0.20% | 1.99% | 14.54% | 19.22% |
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | 4.20B | 4.06B | 4.02B | 3.93B | 3.85B | 3.75B | 3.61B | 3.55B | ||||||
| Medical Growth | 9.14% | 8.26% | 11.16% | 10.94% | 11.36% | 11.90% | 8.80% | 12.72% | ||||||
| Endoscopy | 3.81B | 3.67B | 3.61B | 3.48B | 3.39B | 3.28B | 3.18B | 3.11B | ||||||
| Endoscopy Growth | 12.33% | 12.00% | 13.63% | 11.73% | 11.74% | 15.48% | 18.15% | 20.52% | ||||||
| Instruments | 3.18B | 3.05B | 2.97B | 2.90B | 2.83B | 2.78B | 2.73B | 2.66B | ||||||
| Instruments Growth | 12.31% | 9.64% | 8.72% | 8.87% | 10.32% | 11.83% | 14.04% | 14.40% | ||||||
| Neuro Cranial | 2.49B | 2.42B | 2.22B | 2.02B | 1.84B | 1.67B | 1.62B | 1.57B | ||||||
| Neuro Cranial Growth | 35.05% | 44.50% | 37.48% | 28.53% | 18.79% | 11.90% | 11.98% | 11.79% | ||||||
| Neurovascular | 1.97B | 1.77B | 1.57B | 1.40B | 1.31B | 1.29B | 1.27B | 1.25B | ||||||
| Neurovascular Growth | 50.57% | 37.64% | 24.13% | 12.06% | 6.61% | 6.72% | 6.73% | 5.83% | ||||||
| Other | - | - | - | - | - | - | - | - | - | - | - | - | 302.00M | 292.00M |
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trauma and Extremities | 3.95B | 3.86B | 3.75B | 3.62B | 3.51B | 3.37B | 3.27B | 3.21B | ||||||
| Trauma and Extremities Growth | 12.57% | 14.45% | 14.45% | 12.91% | 11.44% | 10.13% | 9.83% | 10.97% | ||||||
| Knees | 2.66B | 2.59B | 2.54B | 2.50B | 2.45B | 2.39B | 2.34B | 2.30B | ||||||
| Knees Growth | 8.54% | 8.54% | 8.61% | 8.85% | 7.66% | 8.88% | 8.05% | 9.34% | ||||||
| Hips | 1.87B | 1.83B | 1.79B | 1.75B | 1.70B | 1.66B | 1.60B | 1.56B | ||||||
| Hips Growth | 9.45% | 10.51% | 12.21% | 12.29% | 10.36% | 9.97% | 7.18% | 6.91% | ||||||
| Spine | - | - | - | 963.00M | 1.10B | 1.23B | 1.22B | 1.21B | 1.19B | 1.17B | 1.16B | |||
| Spine Growth | - | - | - | -20.08% | -7.74% | 5.22% | 5.10% | 4.69% | 3.75% | 1.65% | - | |||
| Other | 815.00M | 770.00M | 694.00M | 647.00M | 618.00M | 562.00M | 565.00M | 548.00M | ||||||
| Other Growth | 31.88% | 37.01% | 22.83% | 18.07% | 21.41% | 13.31% | 18.45% | 16.10% |
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 19.01B | 18.44B | 17.98B | 17.47B | 16.94B | 16.43B | 16.00B | 15.66B | |||||||||||||||||||||||||
| United States Growth | 12.18% | 12.25% | 12.39% | 11.56% | 11.05% | 11.26% | 10.73% | 11.49% | |||||||||||||||||||||||||
| International | 6.11B | 5.94B | 5.84B | 5.75B | 5.65B | 5.55B | 5.39B | 5.30B | |||||||||||||||||||||||||
| International Growth | 8.10% | 7.12% | 8.31% | 8.39% | 7.84% | 8.32% | 7.66% | 8.09% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.